IL143905A0 - Novel streptococcus antigens - Google Patents

Novel streptococcus antigens

Info

Publication number: IL143905A0
Authority: IL; Israel
Prior art keywords: streptococcus antigens; novel streptococcus; novel; antigens; streptococcus
Prior art date: 1998-12-23

Application number

IL14390599A

Other languages

English (en)

Original Assignee

Shire Biochem Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-23

Filing date

1999-12-20

Publication date

2002-04-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22351610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL143905(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-12-20 Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc

2002-04-21 Publication of IL143905A0 publication Critical patent/IL143905A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Plant Pathology (AREA)
Neurology (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

IL14390599A 1998-12-23 1999-12-20 Novel streptococcus antigens IL143905A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11380098P	1998-12-23	1998-12-23
PCT/CA1999/001218 WO2000039299A2 (en)	1998-12-23	1999-12-20	Streptococcus antigens

Publications (1)

Publication Number	Publication Date
IL143905A0 true IL143905A0 (en)	2002-04-21

Family

ID=22351610

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IL14390599A IL143905A0 (en)	1998-12-23	1999-12-20	Novel streptococcus antigens
IL143905A IL143905A (en)	1998-12-23	2001-06-21	Streptococcus antigens
IL194230A IL194230A (en)	1998-12-23	2008-09-21	Streptococcus antigens and processes for their production

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IL143905A IL143905A (en)	1998-12-23	2001-06-21	Streptococcus antigens
IL194230A IL194230A (en)	1998-12-23	2008-09-21	Streptococcus antigens and processes for their production

Country Status (29)

Country	Link
EP (2)	EP2261358B1 (es)
JP (2)	JP4761623B2 (es)
KR (4)	KR100802198B1 (es)
CN (3)	CN101134775A (es)
AP (1)	AP2001002199A0 (es)
AR (1)	AR029322A1 (es)
AT (1)	ATE394489T1 (es)
AU (1)	AU1764900A (es)
BR (1)	BR9916477A (es)
CA (1)	CA2356836C (es)
CL (1)	CL2009002037A1 (es)
CY (3)	CY1108223T1 (es)
CZ (2)	CZ303675B6 (es)
DE (1)	DE69938670D1 (es)
DK (3)	DK2261358T3 (es)
EA (1)	EA007409B1 (es)
ES (3)	ES2306528T3 (es)
HU (1)	HU229664B1 (es)
IL (3)	IL143905A0 (es)
MX (1)	MXPA01006427A (es)
NO (1)	NO330800B1 (es)
NZ (1)	NZ512574A (es)
OA (1)	OA11736A (es)
PL (3)	PL205041B1 (es)
PT (3)	PT1950302E (es)
TR (2)	TR200200633T2 (es)
UY (1)	UY25877A1 (es)
WO (1)	WO2000039299A2 (es)
ZA (1)	ZA200105114B (es)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4637350B2 (ja)	1998-02-20	2011-02-23	アイディ・バイオメディカル・コーポレイション	グループｂ連鎖球菌抗原
US20030134407A1 (en)	1998-07-27	2003-07-17	Le Page Richard William Falla	Nucleic acids and proteins from Streptococcus pneumoniae
EP1801218A3 (en) *	1998-07-27	2007-10-10	Sanofi Pasteur Limited	Nucleic acids and proteins from streptococcus pneumoniae
JP4689044B2 (ja) *	1998-12-21	2011-05-25	メディミューン，インコーポレーテッド	ワクチン用の肺炎連鎖球菌タンパク質と免疫原断片
US7128918B1 (en)	1998-12-23	2006-10-31	Id Biomedical Corporation	Streptococcus antigens
CA2356836C (en) *	1998-12-23	2011-09-13	Shire Biochem Inc.	Novel streptococcus antigens
US6833134B2 (en)	2000-06-12	2004-12-21	University Of Saskacthewan	Immunization of dairy cattle with GapC protein against Streptococcus infection
US6866855B2 (en)	2000-06-12	2005-03-15	University Of Saskatchewan	Immunization of dairy cattle with GapC protein against Streptococcus infection
DK1294771T3 (da)	2000-06-12	2008-12-15	Univ Saskatchewan	Kimært GapC-protein fra Streptococcus og anvendelse deraf til vaccinering og diagnosticering
US7074415B2 (en)	2000-06-20	2006-07-11	Id Biomedical Corporation	Streptococcus antigens
AU2001270381B2 (en)	2000-06-20	2007-05-24	Id Biomedical Corporation	Streptococcus antigens
WO2002079475A2 (en) *	2001-03-30	2002-10-10	Shire Biochem Inc.	Streptococcus pyogenes antigens and corresponding dna fragments
AU2002317107B2 (en)	2001-07-06	2008-06-12	Id Biomedical Corporation	Group B streptococcus antigens and corresponding DNA fragments
GB0130228D0 (en) *	2001-12-18	2002-02-06	Hansa Medica Ab	Protein
EP1456231A2 (en) *	2001-12-20	2004-09-15	Shire Biochem Inc.	Streptococcus antigens
DK1601770T3 (da) *	2003-03-04	2009-11-02	Intercell Ag	Streptococcus pyogenes antigener
CN102174534A (zh)	2003-04-15	2011-09-07	英特塞尔股份公司	肺炎链球菌抗原
PT1973564T (pt)	2005-12-22	2017-01-24	Glaxosmithkline Biologicals Sa	Vacina compreendendo conjugados polissacarídicos capsulares de streptococcus pneumoniae
GB0607088D0 (en)	2006-04-07	2006-05-17	Glaxosmithkline Biolog Sa	Vaccine
AU2008267208B2 (en)	2007-06-26	2012-01-19	Glaxosmithkline Biologicals S.A.	Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
ES2397488T3 (es) *	2007-07-23	2013-03-07	Sanofi Pasteur Limited	Polipéptidos inmunógenos y anticuerpos monoclonales
BRPI0910963A2 (pt) *	2008-04-16	2016-01-05	Glaxosmithkline Biolog Sa	composição imunogênica, método para tratar ou prevenir doença pneumocócica, e , uso de uma composição imunogênica
WO2010036945A2 (en)	2008-09-26	2010-04-01	The Regents Of The University Of Michigan	Nanoemulsion therapeutic compositions and methods of using the same
RU2536248C2 (ru)	2009-04-30	2014-12-20	Коули Фармасьютикал Груп, Инк.	Пневмококковая вакцина и ее применения
WO2010132833A1 (en)	2009-05-14	2010-11-18	The Regents Of The University Of Michigan	Streptococcus vaccine compositions and methods of using the same
MX2012002639A (es)	2009-09-03	2012-03-14	Pfizer Vaccines Llc	Vacuna de pcsk9.
GB201003920D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Method of treatment
MX2013006255A (es)	2010-12-03	2015-08-05	Sanofi Pasteur Ltd	Composicion para inmunizacion contra streptococcus pneumoniae.
AU2012207089B2 (en)	2011-01-20	2016-04-14	Children's Medical Center Corporation	Vaccines and compositions against Streptococcus pneumoniae
WO2012131504A1 (en)	2011-03-02	2012-10-04	Pfizer Inc.	Pcsk9 vaccine
CN103533953A (zh)	2011-05-17	2014-01-22	葛兰素史密丝克莱恩生物有限公司	针对肺炎链球菌的疫苗
CN105142662B (zh) *	2012-01-05	2017-07-07	德国癌症研究中心	Idh1 r132h突变阳性癌症治疗或诊断的手段与方法
WO2014089706A1 (en) *	2012-12-14	2014-06-19	Sanofi Pasteur, Ltd.	Methods for assessing immunogenicity
HRP20211288T1 (hr)	2014-01-21	2021-11-26	Pfizer Inc.	Kapsularni polisaharidi bakterije streptococcus pneumoniae i njihovi konjugati
US11160855B2 (en)	2014-01-21	2021-11-02	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
BR112016015835B1 (pt)	2014-01-21	2023-12-26	Pfizer Inc	Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae
EP3607966A1 (en)	2014-01-21	2020-02-12	Pfizer Inc	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
ES2701169T3 (es)	2014-02-14	2019-02-21	Pfizer	Conjugados glucoproteicos inmunogénicos
FI3244917T3 (fi)	2015-01-15	2023-05-25	Pfizer	Immunogeenisiä koostumuksia pneumokokkirokotteissa käytettäväksi
KR102225282B1 (ko)	2015-07-21	2021-03-10	화이자 인코포레이티드	접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
GB201518684D0 (en)	2015-10-21	2015-12-02	Glaxosmithkline Biolog Sa	Vaccine
WO2017085586A1 (en)	2015-11-20	2017-05-26	Pfizer Inc.	Immunogenic compositions for use in pneumococcal vaccines
GB201610599D0 (en)	2016-06-17	2016-08-03	Glaxosmithkline Biologicals Sa	Immunogenic Composition
SI3570879T1 (sl)	2017-01-20	2022-06-30	Pfizer Inc.	Imunogenska kompozicija za uporabo v pnevmokoknih cepivih
US11260119B2 (en)	2018-08-24	2022-03-01	Pfizer Inc.	Escherichia coli compositions and methods thereof
WO2020121159A1 (en)	2018-12-12	2020-06-18	Pfizer Inc.	Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
JP7239509B6 (ja)	2019-02-22	2023-03-28	ファイザー・インク	細菌多糖類を精製するための方法
CA3136278A1 (en)	2019-04-10	2020-10-15	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2022001241A (es)	2019-07-31	2022-04-20	Sanofi Pasteur Inc	Composiciones de conjugados neumococicos multivalentes polisacarido - proteina y metodos para usar los mismos.
MX2022005252A (es)	2019-11-01	2022-06-08	Pfizer	Composiciones de escherichia coli y metodos de las mismas.
US20230085173A1 (en)	2020-02-21	2023-03-16	Pfizer Inc.	Purification of saccharides
PE20230170A1 (es)	2020-02-23	2023-02-01	Pfizer	Composiciones de escherichia coli y sus metodos
JP2023546446A (ja)	2020-10-22	2023-11-02	ファイザー・インク	細菌多糖を精製する方法
IL302362A (en)	2020-10-27	2023-06-01	Pfizer	ESCHERICHIA COLI preparations and their methods
US12138302B2 (en)	2020-10-27	2024-11-12	Pfizer Inc.	Escherichia coli compositions and methods thereof
CA3200602A1 (en)	2020-11-04	2022-05-12	Pfizer Inc.	Immunogenic compositions for use in pneumococcal vaccines
US12357681B2 (en)	2020-12-23	2025-07-15	Pfizer Inc.	E. coli FimH mutants and uses thereof
WO2022234416A1 (en)	2021-05-03	2022-11-10	Pfizer Inc.	Vaccination against pneumoccocal and covid-19 infections
WO2022234405A1 (en)	2021-05-03	2022-11-10	Pfizer Inc.	Vaccination against bacterial and betacoronavirus infections
PE20240090A1 (es)	2021-05-28	2024-01-16	Pfizer	Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos
EP4346893A2 (en)	2021-05-28	2024-04-10	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CA3247998A1 (en)	2022-01-13	2023-07-20	Pfizer Inc.	Immunogenic compositions based on conjugated capsular saccharidic antigens and their uses
US20250163484A1 (en)	2022-02-25	2025-05-22	Pfizer Inc.	Methods for Incorporating Azido Groups in Bacterial Capsular Polysaccharides
AU2023268745A1 (en)	2022-05-11	2024-11-07	Pfizer Inc.	Process for producing of vaccine formulations with preservatives
WO2024084397A1 (en)	2022-10-19	2024-04-25	Pfizer Inc.	Vaccination against pneumoccocal and covid-19 infections
WO2024110827A1 (en)	2022-11-21	2024-05-30	Pfizer Inc.	Methods for preparing conjugated capsular saccharide antigens and uses thereof
KR20250107930A (ko)	2022-11-22	2025-07-14	화이자 인코포레이티드	접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
CN120513083A (zh)	2022-12-01	2025-08-19	辉瑞大药厂	肺炎链球菌缀合物疫苗制剂
EP4661911A1 (en)	2023-02-10	2025-12-17	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024201324A2 (en)	2023-03-30	2024-10-03	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
KR20250169621A (ko)	2023-04-14	2025-12-03	화이자 인코포레이티드	접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
WO2024224266A1 (en)	2023-04-24	2024-10-31	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2024241172A2 (en)	2023-05-19	2024-11-28	Glaxosmithkline Biologicals Sa	Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection
WO2025057078A1 (en)	2023-09-14	2025-03-20	Pfizer Inc.	Adjuvanted immunogenic compositions comprising conjugated pneumococcal capsular saccharide antigens and uses thereof
WO2025133971A1 (en)	2023-12-23	2025-06-26	Pfizer Inc.	Improved methods for producing bacterial capsular saccharide glycoconjugates
WO2025186705A2 (en)	2024-03-06	2025-09-12	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2025191415A1 (en)	2024-03-11	2025-09-18	Pfizer Inc.	Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof
WO2025219904A1 (en)	2024-04-19	2025-10-23	Pfizer Inc.	Improved methods for producing glycoconjugates by reductive amination in aprotic solvent
WO2025219908A2 (en)	2024-04-19	2025-10-23	Pfizer Inc.	Media and fermentation methods for polysaccharide production in bacterial cell culture

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4425437A (en)	1979-11-05	1984-01-10	Genentech, Inc.	Microbial polypeptide expression vehicle
US4431739A (en)	1979-11-05	1984-02-14	Genentech, Inc.	Transformant bacterial culture capable of expressing heterologous protein
US4338397A (en)	1980-04-11	1982-07-06	President And Fellows Of Harvard College	Mature protein synthesis
SG47049A1 (en) *	1993-03-19	1998-03-20	Gunnar Lindahl	Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit
KR19990022742A (ko) *	1995-06-07	1999-03-25	샤르레 아. 테시에르	스트렙토코커스 속 유래의 hsp70 계열의 쇼크 단백질
US5928895A (en) *	1996-09-24	1999-07-27	Smithkline Beecham Corporation	IgA Fc binding protein
US5882896A (en) *	1996-09-24	1999-03-16	Smithkline Beecham Corporation	M protein
US6420135B1 (en) *	1996-10-31	2002-07-16	Human Genome Sciences, Inc.	Streptococcus pneumoniae polynucleotides and sequences
EP1017828A1 (en) *	1997-09-24	2000-07-12	Regents Of The University Of Minnesota	HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)
JP2002516251A (ja) *	1998-04-23	2002-06-04	ユーエイビーリサーチファンデーション	肺炎球菌表面プロテインＣ（ＰｓｐＣ）のエピトープ領域およびその菌株選択、ならびにそのための使用法
CN1318103A (zh) *	1998-07-27	2001-10-17	微生物技术有限公司	肺炎链球菌的核酸和蛋白质
WO2000006737A2 (en) *	1998-07-27	2000-02-10	Microbial Technics Limited	Streptococcus pneumoniae proteins and nucleic acid molecules
JP2002526082A (ja) *	1998-09-24	2002-08-20	リージェンツオブザユニバーシティオブミネソタ	ストレプトコッカス・ニューモニア由来のヒト補体ｃ３分解ポリペプチド
JP4689044B2 (ja) *	1998-12-21	2011-05-25	メディミューン，インコーポレーテッド	ワクチン用の肺炎連鎖球菌タンパク質と免疫原断片
CA2356836C (en) *	1998-12-23	2011-09-13	Shire Biochem Inc.	Novel streptococcus antigens

1999
- 1999-12-20 CA CA2356836A patent/CA2356836C/en not_active Expired - Fee Related
- 1999-12-20 DE DE69938670T patent/DE69938670D1/de not_active Expired - Lifetime
- 1999-12-20 CN CNA2007101481600A patent/CN101134775A/zh active Pending
- 1999-12-20 WO PCT/CA1999/001218 patent/WO2000039299A2/en not_active Ceased
- 1999-12-20 PT PT81553174T patent/PT1950302E/pt unknown
- 1999-12-20 KR KR1020017007963A patent/KR100802198B1/ko not_active Expired - Fee Related
- 1999-12-20 AT AT99960748T patent/ATE394489T1/de active
- 1999-12-20 TR TR2002/00633T patent/TR200200633T2/xx unknown
- 1999-12-20 JP JP2000591190A patent/JP4761623B2/ja not_active Expired - Fee Related
- 1999-12-20 DK DK10180372.4T patent/DK2261358T3/da active
- 1999-12-20 DK DK08155317.4T patent/DK1950302T3/da active
- 1999-12-20 EA EA200100565A patent/EA007409B1/ru not_active IP Right Cessation
- 1999-12-20 NZ NZ512574A patent/NZ512574A/xx not_active IP Right Cessation
- 1999-12-20 ES ES99960748T patent/ES2306528T3/es not_active Expired - Lifetime
- 1999-12-20 AP APAP/P/2001/002199A patent/AP2001002199A0/en unknown
- 1999-12-20 CN CNB998149047A patent/CN1191362C/zh not_active Expired - Fee Related
- 1999-12-20 IL IL14390599A patent/IL143905A0/xx unknown
- 1999-12-20 HU HU0104774A patent/HU229664B1/hu not_active IP Right Cessation
- 1999-12-20 ES ES10180372.4T patent/ES2480417T3/es not_active Expired - Lifetime
- 1999-12-20 DK DK99960748T patent/DK1141306T3/da active
- 1999-12-20 CZ CZ20012161A patent/CZ303675B6/cs not_active IP Right Cessation
- 1999-12-20 TR TR2001/02497T patent/TR200102497T2/xx unknown
- 1999-12-20 KR KR1020067025282A patent/KR100891398B1/ko not_active Expired - Fee Related
- 1999-12-20 CN CNB2005100037492A patent/CN100398653C/zh not_active Expired - Fee Related
- 1999-12-20 PL PL382437A patent/PL205041B1/pl unknown
- 1999-12-20 ES ES08155317T patent/ES2400280T3/es not_active Expired - Lifetime
- 1999-12-20 KR KR1020107009285A patent/KR101078919B1/ko not_active Expired - Fee Related
- 1999-12-20 EP EP10180372.4A patent/EP2261358B1/en not_active Expired - Lifetime
- 1999-12-20 OA OA1200100165A patent/OA11736A/en unknown
- 1999-12-20 PT PT101803724T patent/PT2261358E/pt unknown
- 1999-12-20 MX MXPA01006427A patent/MXPA01006427A/es not_active IP Right Cessation
- 1999-12-20 KR KR1020087008264A patent/KR101170203B1/ko not_active Expired - Fee Related
- 1999-12-20 PT PT99960748T patent/PT1141306E/pt unknown
- 1999-12-20 AU AU17649/00A patent/AU1764900A/en not_active Abandoned
- 1999-12-20 PL PL382438A patent/PL204073B1/pl not_active IP Right Cessation
- 1999-12-20 CZ CZ20100674A patent/CZ302790B6/cs not_active IP Right Cessation
- 1999-12-20 PL PL349777A patent/PL206576B1/pl unknown
- 1999-12-20 BR BR9916477-9A patent/BR9916477A/pt active Search and Examination
- 1999-12-20 EP EP99960748A patent/EP1141306B1/en not_active Expired - Lifetime
- 1999-12-23 AR ARP990106746A patent/AR029322A1/es not_active Application Discontinuation
- 1999-12-23 UY UY25877A patent/UY25877A1/es unknown
2001
- 2001-06-19 NO NO20013045A patent/NO330800B1/no not_active IP Right Cessation
- 2001-06-21 ZA ZA200105114A patent/ZA200105114B/en unknown
- 2001-06-21 IL IL143905A patent/IL143905A/en not_active IP Right Cessation
2008
- 2008-07-29 CY CY20081100787T patent/CY1108223T1/el unknown
- 2008-09-21 IL IL194230A patent/IL194230A/en not_active IP Right Cessation
2009
- 2009-11-05 CL CL2009002037A patent/CL2009002037A1/es unknown
2010
- 2010-02-09 JP JP2010026521A patent/JP5039802B2/ja not_active Expired - Fee Related
2012
- 2012-12-27 CY CY20121101268T patent/CY1114722T1/el unknown
2014
- 2014-07-16 CY CY20141100536T patent/CY1115340T1/el unknown

Also Published As

Publication number	Publication date
AR029322A1 (es)	2003-06-25
MXPA01006427A (es)	2002-06-04
CN1654657A (zh)	2005-08-17
EA007409B1 (ru)	2006-10-27
CZ20012161A3 (cs)	2001-10-17
DK1950302T3 (da)	2013-01-14
IL194230A (en)	2013-12-31
JP2002533123A (ja)	2002-10-08
HUP0104774A3 (en)	2007-10-29
CL2009002037A1 (es)	2010-06-25
NO20013045L (no)	2001-08-20
HU229664B1 (en)	2014-04-28
EP2261358A3 (en)	2011-02-23
KR100802198B1 (ko)	2008-02-11
ZA200105114B (en)	2002-11-21
PL349777A1 (en)	2002-09-09
IL143905A (en)	2011-05-31
DK1141306T3 (da)	2008-08-18
CN1332803A (zh)	2002-01-23
NO330800B1 (no)	2011-07-18
UY25877A1 (es)	2000-08-21
DK2261358T3 (da)	2014-07-28
PT1950302E (pt)	2013-01-16
EP2261358A2 (en)	2010-12-15
HK1118575A1 (en)	2009-02-13
CY1108223T1 (el)	2014-02-12
TR200102497T2 (tr)	2002-01-21
PL206576B1 (pl)	2010-08-31
PT2261358E (pt)	2014-07-30
WO2000039299A3 (en)	2000-11-02
JP5039802B2 (ja)	2012-10-03
PL205041B1 (pl)	2010-03-31
ES2480417T3 (es)	2014-07-28
CY1114722T1 (el)	2016-10-05
ES2400280T3 (es)	2013-04-08
ES2306528T3 (es)	2008-11-01
DE69938670D1 (de)	2008-06-19
KR101170203B1 (ko)	2012-07-31
CY1115340T1 (el)	2017-01-04
NO20013045D0 (no)	2001-06-19
EP2261358B1 (en)	2014-05-14
CN1191362C (zh)	2005-03-02
CZ303675B6 (cs)	2013-02-27
ATE394489T1 (de)	2008-05-15
OA11736A (en)	2005-06-12
PT1141306E (pt)	2008-07-30
TR200200633T2 (tr)	2002-06-21
KR20010104693A (ko)	2001-11-26
BR9916477A (pt)	2004-06-22
CZ302790B6 (cs)	2011-11-09
KR20060134227A (ko)	2006-12-27
KR20100063814A (ko)	2010-06-11
CN100398653C (zh)	2008-07-02
NZ512574A (en)	2004-03-26
CN101134775A (zh)	2008-03-05
KR100891398B1 (ko)	2009-04-02
AP2001002199A0 (en)	2001-09-30
IL194230A0 (en)	2011-08-01
JP4761623B2 (ja)	2011-08-31
EP1141306B1 (en)	2008-05-07
CA2356836A1 (en)	2000-07-06
PL204073B1 (pl)	2009-12-31
AU1764900A (en)	2000-07-31
KR101078919B1 (ko)	2011-11-01
KR20080036666A (ko)	2008-04-28
JP2010142246A (ja)	2010-07-01
EP1141306A2 (en)	2001-10-10
CA2356836C (en)	2011-09-13
WO2000039299A2 (en)	2000-07-06
HUP0104774A2 (hu)	2002-04-29
EA200100565A1 (ru)	2002-04-25

Publication	Publication Date	Title
IL194230A0 (en)	2011-08-01	Novel streptococcus antigens
IL153558A0 (en)	2003-07-06	Streptococcus antigens
ZA991325B (en)	1999-08-20	Novel group B streptococcus antigens.
GB9809839D0 (en)	1998-07-08	Antibody
AU2002351623A8 (en)	2003-07-09	Streptococcus antigens
GB9603256D0 (en)	1996-04-17	Antibodies
PL341642A1 (en)	2001-04-23	Novel macrolydes
PL341160A1 (en)	2001-03-26	Novel superficial antigen
PL346369A1 (en)	2002-02-11	Streptococcus suis
EP1068213A4 (en)	2001-05-02	SILOXANES WITH AMINO-ORGANIC FUNCTIONAL GROUP
DE60023158D1 (en)	2006-02-23	Phagenresistentes streptococcus thermophilus
GB9818915D0 (en)	1998-10-21	Antibodies
GB9828700D0 (en)	1999-02-17	Antibody
IL138958A0 (en)	2001-11-25	Streptococcus preparation
GB9928678D0 (en)	2000-02-02	Streptococcus pneumoniae antigens
GB9819411D0 (en)	1998-10-28	Antibodies
GB9825184D0 (en)	1999-01-13	Antigen
GB9807062D0 (en)	1998-06-03	Immune response
GB9800760D0 (en)	1998-03-11	Antigens
GB9726147D0 (en)	1998-02-11	Antigens
GB9915419D0 (en)	1999-09-01	Antigens
PL345071A1 (en)	2001-12-03	Novel biocontrol agents
GB9822143D0 (en)	1998-12-02	Antigens
GB9819015D0 (en)	1998-10-28	Antigens
TW407677U (en)	2000-10-01	Form